Anti-inflammatory cytokine suppression (COX-2, IL-6, TNF-)
For example, those who follow vegan or vegetarian diets or are over the age of 60 may need supplementation (Pawlak, 2014
Additionally, because many people with diabetes or who are overweight may control their condition with diet, other medications and therapies, or choose to not seek treatment, not all people who meet these clinical criteria would use GLP-1 drugs
GLP-1 Receptor Agonists, Obesity, and Cardiovascular Disease Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were originally developed to improve glycemic control in type 2 diabetes but have since demonstrated benefits in weight reduction and cardiovascular risk modification, including in people without diabetes
However, the precise role of 15LO1 and its products in disease pathogenesis remains enigmatic